E2 ModerateModerate confidencePEM not requiredObservationalPeer-reviewedReviewed
Predictors of outcome in a multi-component treatment program for chronic fatigue syndrome.
Kempke, Stefan, Goossens, Lutgarde, Luyten, Patrick et al. · Journal of affective disorders · 2010 · DOI
Quick Summary
This study followed 178 ME/CFS patients through a multi-component treatment program to identify which patient characteristics predicted who would improve. The researchers found that only depression severity before treatment started was associated with how fatigued patients remained after treatment—patients with higher depression were more likely to stay fatigued afterward. This suggests that addressing depression alongside other ME/CFS treatments may be important.
Why It Matters
Depression is common in ME/CFS and often overlooked as a treatment target. This study provides empirical evidence that depression severity before treatment may influence treatment outcomes, suggesting that integrated approaches addressing both ME/CFS symptoms and depression could improve patient results.
Observed Findings
- Pre-treatment depression severity was significantly associated with post-treatment fatigue levels
- Pre-treatment depression severity was significantly associated with fatigue improvement
- Other tested variables (somatic attributions, psychological attributions, sense of control, physical activity, functional impairment, and somatic focus) were not significantly associated with treatment outcome
- The study included 178 CFS patients in a multi-component treatment program at a tertiary care center
Inferred Conclusions
- Depression severity may be the most important factor within the cognitive-behavioral model for predicting post-treatment fatigue in CFS
- CFS treatment programs should prioritize assessment and management of depression symptoms
- Other cognitive-behavioral factors tested may be less relevant as predictors of treatment outcome, or may require different measurement or analysis approaches
Remaining Questions
- Does treating depression concurrently with CFS improve treatment outcomes compared to treating CFS alone?
- Do the results persist at long-term follow-up, and if so, for how long?
- Which specific depression treatments (medication, psychotherapy, or both) are most effective within a CFS treatment program?
What This Study Does Not Prove
This study does not prove that depression causes poor ME/CFS treatment outcomes or that treating depression will improve CFS outcomes—it only shows an association. The lack of a control group and long-term follow-up means we cannot determine if these results persist over time or compare treatment effects to natural recovery or placebo.
Tags
Symptom:Fatigue
Method Flag:Weak Case DefinitionNo ControlsExploratory Only
Metadata
- DOI
- 10.1016/j.jad.2010.01.073
- PMID
- 20167377
- Review status
- Editor reviewed
- Evidence level
- Single-study or moderate support from human research
- Last updated
- 12 April 2026
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Contribute
Private, reviewed by a human. Not a public comment thread.